Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Borrelia burgdorferi-induced inflammation facilitates spirochete adaptation and variable major protein-like sequence locus recombination.

Anguita J, Thomas V, Samanta S, Persinski R, Hernanz C, Barthold SW, Fikrig E.

J Immunol. 2001 Sep 15;167(6):3383-90.

2.

Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection.

Coutte L, Botkin DJ, Gao L, Norris SJ.

PLoS Pathog. 2009 Feb;5(2):e1000293. doi: 10.1371/journal.ppat.1000293. Epub 2009 Feb 13.

3.

Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle.

Ohnishi J, Schneider B, Messer WB, Piesman J, de Silva AM.

J Bacteriol. 2003 Aug;185(15):4432-41.

4.

Borrelia burgdorferi gene expression in vivo and spirochete pathogenicity.

Anguita J, Samanta S, Revilla B, Suk K, Das S, Barthold SW, Fikrig E.

Infect Immun. 2000 Mar;68(3):1222-30.

5.

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.

Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.

J Immunol. 2001 Jun 15;166(12):7398-403.

6.

Infection and inflammation in skeletal muscle from nonhuman primates infected with different genospecies of the Lyme disease spirochete Borrelia burgdorferi.

Cadavid D, Bai Y, Dail D, Hurd M, Narayan K, Hodzic E, Barthold SW, Pachner AR.

Infect Immun. 2003 Dec;71(12):7087-98.

7.

Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi.

Zhang JR, Norris SJ.

Infect Immun. 1998 Aug;66(8):3689-97. Erratum in: Infect Immun 1999 Jan;67(1):468.

9.

Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.

Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, Fikrig E.

Infect Immun. 2004 Oct;72(10):5759-67.

10.

Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector.

Indest KJ, Howell JK, Jacobs MB, Scholl-Meeker D, Norris SJ, Philipp MT.

Infect Immun. 2001 Nov;69(11):7083-90.

11.

Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Rogovskyy AS, Gillis DC, Ionov Y, Gerasimov E, Zelikovsky A.

Infect Immun. 2016 Dec 29;85(1). pii: e00890-16. doi: 10.1128/IAI.00890-16. Print 2017 Jan.

12.

Variable VlsE is critical for host reinfection by the Lyme disease spirochete.

Rogovskyy AS, Bankhead T.

PLoS One. 2013 Apr 8;8(4):e61226. doi: 10.1371/journal.pone.0061226. Print 2013.

13.

Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection of laboratory mice.

Feng S, Hodzic E, Stevenson B, Barthold SW.

Infect Immun. 1998 Jun;66(6):2827-35.

14.
16.
17.

Molecular adaptation of Borrelia burgdorferi in the murine host.

Liang FT, Nelson FK, Fikrig E.

J Exp Med. 2002 Jul 15;196(2):275-80.

18.

Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.

Scheckelhoff MR, Telford SR, Hu LT.

Vaccine. 2006 Mar 10;24(11):1949-57. Epub 2005 Nov 4.

19.

Borrelia burgdorferi outer surface protein (osp) B expression independent of ospA.

Liang FT, Caimano MJ, Radolf JD, Fikrig E.

Microb Pathog. 2004 Jul;37(1):35-40.

PMID:
15194158
20.

Supplemental Content

Support Center